| Published Application/Species/Sample/Dilution | Reference |
|---|
- ELISA; human; loading ...; fig 1a
| Ercan Herbst E, Ehrig J, Schöndorf D, Behrendt A, Klaus B, Gomez Ramos B, et al. A post-translational modification signature defines changes in soluble tau correlating with oligomerization in early stage Alzheimer's disease brain. Acta Neuropathol Commun. 2019;7:192 pubmed publisher |
- immunocytochemistry; human; 1:100; tbl 2
- western blot; human; 1:1000; tbl 1
- western blot; mouse
| Ercan E, Eid S, Weber C, Kowalski A, Bichmann M, Behrendt A, et al. A validated antibody panel for the characterization of tau post-translational modifications. Mol Neurodegener. 2017;12:87 pubmed publisher |
| Montoliu Gaya L, Benedet A, Tissot C, Vrillon A, Ashton N, Brum W, et al. Mass spectrometric simultaneous quantification of tau species in plasma shows differential associations with amyloid and tau pathologies. Nat Aging. 2023;3:661-669 pubmed publisher |
| Mil xe0 Alom xe0 M, Ashton N, Shekari M, Salvad xf3 G, Ortiz Romero P, Montoliu Gaya L, et al. Plasma p-tau231 and p-tau217 as state markers of amyloid-β pathology in preclinical Alzheimer's disease. Nat Med. 2022;28:1797-1801 pubmed publisher |
| Chatterjee S, Bahl E, Mukherjee U, Walsh E, Shetty M, Yan A, et al. Endoplasmic reticulum chaperone genes encode effectors of long-term memory. Sci Adv. 2022;8:eabm6063 pubmed publisher |
| Snellman A, Lantero Rodriguez J, Emer x161 i x10d A, Vrillon A, Karikari T, Ashton N, et al. N-terminal and mid-region tau fragments as fluid biomarkers in neurological diseases. Brain. 2022;145:2834-2848 pubmed publisher |
| Ashton N, Benedet A, Pascoal T, Karikari T, Lantero Rodriguez J, Brum W, et al. Cerebrospinal fluid p-tau231 as an early indicator of emerging pathology in Alzheimer's disease. EBioMedicine. 2022;76:103836 pubmed publisher |
| Bichmann M, Prat Oriol N, Ercan Herbst E, Sch xf6 ndorf D, Gomez Ramos B, Schw xe4 rzler V, et al. SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer's disease. Mol Neurodegener. 2021;16:46 pubmed publisher |
| Karikari T, Emer x161 i x10d A, Vrillon A, Lantero Rodriguez J, Ashton N, Kramberger M, et al. Head-to-head comparison of clinical performance of CSF phospho-tau T181 and T217 biomarkers for Alzheimer's disease diagnosis. Alzheimers Dement. 2021;17:755-767 pubmed publisher |
| Karikari T, Keeling S, Hill E, Lantero Rodrı Guez J, Nagel D, Becker B, et al. Extensive Plasmid Library to Prepare Tau Protein Variants and Study Their Functional Biochemistry. ACS Chem Neurosci. 2020;11:3117-3129 pubmed publisher |
| Haenig C, Atias N, Taylor A, Mazza A, Schaefer M, Russ J, et al. Interactome Mapping Provides a Network of Neurodegenerative Disease Proteins and Uncovers Widespread Protein Aggregation in Affected Brains. Cell Rep. 2020;32:108050 pubmed publisher |
| Lantero Rodriguez J, Karikari T, Suarez Calvet M, Troakes C, King A, Emersic A, et al. Plasma p-tau181 accurately predicts Alzheimer's disease pathology at least 8 years prior to post-mortem and improves the clinical characterisation of cognitive decline. Acta Neuropathol. 2020;140:267-278 pubmed publisher |
| Seraf xed n V, Razzino C, Gamella M, Pedrero M, Povedano E, Montero Calle A, et al. Disposable immunoplatforms for the simultaneous determination of biomarkers for neurodegenerative disorders using poly(amidoamine) dendrimer/gold nanoparticle nanocomposite. Anal Bioanal Chem. 2021;413:799-811 pubmed publisher |
| Karikari T, Pascoal T, Ashton N, Janelidze S, Benedet A, Rodriguez J, et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 2020;19:422-433 pubmed publisher |
| Rosenberg R, Fu M, Lambracht Washington D. Active full-length DNA Aβ42 immunization in 3xTg-AD mice reduces not only amyloid deposition but also tau pathology. Alzheimers Res Ther. 2018;10:115 pubmed publisher |
| Sengupta U, Portelius E, Hansson O, Farmer K, Castillo Carranza D, Woltjer R, et al. Tau oligomers in cerebrospinal fluid in Alzheimer's disease. Ann Clin Transl Neurol. 2017;4:226-235 pubmed publisher |
| Kotfis K, Zegan Barańska M, Szydłowski Ł, Zukowski M, Ely E. Methods of pain assessment in adult intensive care unit patients - Polish version of the CPOT (Critical Care Pain Observation Tool) and BPS (Behavioral Pain Scale). Anaesthesiol Intensive Ther. 2017;49:66-72 pubmed publisher |
| Irwin D, Cohen T, Grossman M, Arnold S, Xie S, Lee V, et al. Acetylated tau, a novel pathological signature in Alzheimer's disease and other tauopathies. Brain. 2012;135:807-18 pubmed publisher |
